Germany’s PharmaSGP Predicts Market Turnaround Despite Difficult First Half
Germany's PharmaSGP blamed ongoing lockdowns for falling first-half sales, but said it could see light at the end of the tunnel, with the OTC market expected to recover in the second half of the year.
You may also be interested in...
GSK divests non-core German OTC portfolio to local player PharmaSGP, which says it has gained "established brands" in the pain-relief and sleep-aid categories.
UK consumer healthcare industry association PAGB has joined forces with a number of like-minded groups to call on the government to implement a national strategy for self-care to help relieve pressure on the NHS.
Is your company in the running to win an OTC Marketing Award on 1 December?